Hsbc Holdings PLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $5.39 Million - $6.53 Million	-6,100 Reduced 19.55%	25,100 $26.4 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $13.5 Million - $14.8 Million	-14,900 Reduced 32.32%	31,200 $30 Million
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $3.33 Million - $3.79 Million	4,300 Added 10.29%	46,100 $40.5 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $3.74 Million - $4.56 Million	5,400 Added 14.84%	41,800 $34.4 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $15.7 Million - $18.6 Million	22,400 Added 160.0%	36,400 $26.2 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $8.51 Million - $10.3 Million	12,500 Added 833.33%	14,000 $11.5 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $803,558 - $1.01 Million	-1,400 Reduced 48.28%	1,500 $1.05 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $1.43 Million - $1.92 Million	2,600 Added 866.67%	2,900 $1.73 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $1.37 Million - $1.61 Million	-2,300 Reduced 88.46%	300 $212,000
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $1.25 Million - $1.54 Million	-2,300 Reduced 46.94%	2,600 $1.64 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $57,403 - $68,096	-100 Reduced 2.0%	4,900 $2.99 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $144 Million - $170 Million	-304,400 Reduced 98.38%	5,000 $2.79 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $126 Million - $154 Million	281,800 Added 1021.01%	309,400 $146 Million
Q4 2020 Feb 25, 2021	BUY	$478.3 - $607.98 $3.25 Million - $4.13 Million	6,800 Added 32.69%	27,600 $13.3 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $4.83 Million - $6.31 Million	-9,800 Reduced 32.03%	20,800 $13 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $2.55 Million - $3.76 Million	7,600 Added 33.04%	30,600 $14.8 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $5.02 Million - $6.89 Million	-18,300 Reduced 44.31%	23,000 $8.6 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $164,076 - $191,034	-600 Reduced 1.43%	41,300 $11.5 Million
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $5.51 Million - $7.63 Million	18,400 Added 78.3%	41,900 $13.1 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $4.2 Million - $4.97 Million	-11,300 Reduced 32.47%	23,500 $9.65 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $2.59 Million - $3.1 Million	7,700 Added 28.41%	34,800 $13 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $4.04 Million - $4.7 Million	11,500 Added 73.72%	27,100 $10.9 Million
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $512,280 - $620,982	1,800 Added 13.04%	15,600 $5.38 Million
Q1 2018 May 11, 2018	SELL	$315.82 - $393.78 $442,148 - $551,292	-1,400 Reduced 9.21%	13,800 $4.75 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $1.38 Million - $1.61 Million	3,200 Added 26.67%	15,200 $6.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,000	12,000 $5.89 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account